Cleared Traditional

K854929 - OXOID STREPTOCOCAL GROUPING KIT

K854929 is an FDA 510(k) clearance for OXOID STREPTOCOCAL GROUPING KIT, manufactured by Oxoid U.S.A., Inc.. The device is a Class 1 Microbiology device with product code GTZ cleared through the Traditional 510(k) pathway after a 91-day FDA review.

K854929 · Oxoid U.S.A., Inc. · Microbiology device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Mar 1986
Decision
91d
Days
Class 1
Risk

K854929 is an FDA 510(k) clearance for the OXOID STREPTOCOCAL GROUPING KIT. Classified as Antisera, All Groups, Streptococcus Spp. (product code GTZ), Class I - General Controls.

Submitted by Oxoid U.S.A., Inc. (Columbia, US). The FDA issued a Cleared decision on March 11, 1986 after a review of 91 days - within the typical 510(k) review window.

This device falls under the Microbiology FDA review panel, regulated under 21 CFR 866.3740 - the FDA microbiology device framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Standard predicate-based submission. Standard predicate reliance. This clearance follows a standard predicate-based equivalence path within the Microbiology review framework, consistent with the majority of Class II 510(k) submissions.

View all Oxoid U.S.A., Inc. devices

FDA 510(k) Submission Details - K854929

510(k) Number K854929 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received December 10, 1985
Decision Date March 11, 1986
Days to Decision 91 days
Submission Type Traditional
Review Panel Microbiology (MI)
Summary -
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
11d faster than avg
Panel avg: 102d · This submission: 91d
Pathway characteristics
Predicate-based equivalence.

GTZ Device Classification - Class 1, General Controls

Product Code GTZ Antisera, All Groups, Streptococcus Spp.
Device Class Class 1 - General Controls
CFR Regulation 21 CFR 866.3740
What this classification means

Class I devices are subject to general controls only and most are exempt from 510(k) premarket notification. They represent the lowest regulatory burden in the FDA device framework.

Regulatory Peers - GTZ Antisera, All Groups, Streptococcus Spp.

All 89
Devices cleared under the same product code (GTZ) and FDA review panel - the closest regulatory comparables to K854929.
LEECO-SCREEN, STREP A (EIA)
K860947 · Leeco Diagnostics, Inc. · May 1986
TANDEM ICON STREP A IMMUNOENZYMETRIC ASSAY KIT
K860778 · Hybritech, Inc. · Apr 1986
DIFCO STREP A LATEX TEST
K854978 · Difco Laboratories, Inc. · Mar 1986
IMMUNOSCAN RAPID DIRECT GROUP A STREP TEST
K854447 · American Micro Scan · Jan 1986
ABBOTT STREP A P.S.D.
K852266 · Abbott Laboratories · Dec 1985
PHADIRECT STREP A TEST
K854150 · Pharmacia, Inc. · Oct 1985